Array An in-depth viewpoint on the current taxation situation for pharmaceutical companies operating in Belgium today, looking at incentive programs and relative positioning in Europe. Mr Eynatten, can you please provide our readers with an overview of the value added services that Deloitte offers to the life sciences industry in…
Almirall Austria Almirall was opened through the acquisition of Hermal in 2007. What impact did that have on Almirall’s operations in central Europe, and where does Austria fit in Almirall’s picture today? Nowadays Almirall Austria plays a significant role amongst the Almirall-affiliates. The Austrian subsidiary has been meeting and exceeding the expectations…
Array Donald Niesten and Omer Saka discuss the current dynamics of the healthcare and pharmaceutical sectors in Belgium, the challenges of entering the market and the issue of effective communication with stakeholders, as well as offering opinions on the merits of ‘clusterization’. Deloitte is certainly renowned for its strong network…
Phebra Australia Can you start by giving our readers a brief overview of the company’s history here and your most notable achievements? Initially the company was founded as a small distributor of relatively specialized pharmaceutical products. Over the years we saw a growing demand for these special, difficult to manufacture drugs or…
MicroConstants China Although MicroConstants traces its history back to 1998 in San Diego, you co-founded the China operations in 2007. What’s the story behind how that came about? It all began when I met Gilbert Lam, the President of MicroConstants San Diego, at a CRO open house in San Diego ten years…
Cardinal Health China We last met with you as the head of Zuellig in 2009. Obviously, a lot has changed since then; from both a sector and corporate point of view, what have been the most important changes since our last report? As you will probably hear from other people, the most significant…
Australia Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting recent milestones & achievements? George Clinical is an important division of the Institute, contributing to its research goals in several ways: We provide operations teams to deliver clinical trials i.e. the (usually) randomized,…
The George Institute For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in cardiovascular physiology I moved to Boston to work at MIT on neurotransmitters in the brain and the effects on blood pressure. From Boston I moved to Hammersmith hospital in London…
Rare Voices Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in 2011. Can you please begin with giving our readers an introduction to Rare Voices and explain to our readers why the organization was needed? It is estimated that there are disease community…
Health Sciences Authority HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore. However, we are quite unique because we also run the national blood service and we have an Applied Sciences Group that looks into laboratory…
Schülke & Mayr Austria 2012 represents the 123rd anniversary of Schülke&Mayr. There have been many changes over the years, but do you think the ideals and values of today reflect the original vision set out by the founders in 1889? Generally, this is true. But of course, many things changed over the course of…
BioSingapore In addition to being the director of strategic planning at Quintiles you are also the Chairman of BioSingapore. In this context, can you please introduce BioSingapore and describe its main objectives? BioSingapore was created in 2004 by the Singapore Economic Development Board (EDB) to create an interactive platform for the…
See our Cookie Privacy Policy Here
